Sign in

CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company

Decoy Therapeutics Inc.

Sign in to watch
Ticker
DCOY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465087339
Phone
346-772-0346
Business address
2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
Former names
Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
  1. 8-K Event Other events
  2. 4 Grant or award Exec VP Finance, CFO acquired 6,432 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 14,300 shares (grant or award)
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 8-K Event Other events
  7. 4 Grant or award Director acquired 1,440 shares (grant or award)
  8. 4 Grant or award Director acquired 1,440 shares (grant or award)
  9. 4 Grant or award Director acquired 1,440 shares (grant or award)
  10. 4 Grant or award Director acquired 1,440 shares (grant or award)
  11. 4 Grant or award Director acquired 1,440 shares (grant or award)
  12. 4 Grant or award Director acquired 1,440 shares (grant or award)
  13. 4 Grant or award Exec VP Finance, CFO acquired 8,000 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 20,000 shares (grant or award)
  15. 4/A Grant or award Chief Executive Officer acquired 2,693 shares (grant or award)
  16. 4/A Grant or award Exec VP Finance, CFO acquired 1,488 shares (grant or award)
  17. 8-K Event Other events
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 4/A Grant or award Chief Executive Officer acquired 10,000 shares (grant or award)

Page 10 of 38 · 744 filings